ID
16702
Descripción
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Relapse Report
Link
https://clinicaltrials.gov/ct2/show/NCT00373425
Palabras clave
Versiones (1)
- 1/8/16 1/8/16 -
Subido en
1 de agosto de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Relapse Report, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Relapse Report, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Descripción
New Lesion Specification
Descripción
Lesion number
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0221198
- UMLS CUI [1,2]
- C0750480
Descripción
Provide relevant code number for Method of Evaluation and Disease Site. lf "Other'' applies, use code 99 and specify.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2911685
Descripción
Method of Evalution
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2911685
Descripción
Site of Lesion
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0449685
Descripción
Disease Site
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0449685
Descripción
Date of Evaluation
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0221198
- UMLS CUI [1,3]
- C0031809
Similar models
Relapse Report, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C0750480 (UMLS CUI [1,2])
C0221198 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])